[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"air-in-line-alarm\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:air-in-line-alarm":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100648287","air-in-line-alarms-during-antineoplastic-drug-infusion-100648287",false,"NCT07718711","Air-in-Line Alarms During Antineoplastic Drug Infusion","Innovation in Antineoplastic Drug Infusion: A Multiphase Observational Study of Air-in-Line Alarms, Safety, and Therapeutic Continuity","AIR-ONC","Inclusion Criteria:\n\n* Healthcare professionals involved in the administration of antineoplastic drugs in participating oncology centres.\n* Employment in a participating study site during the study period.\n* Direct involvement in routine intravenous antineoplastic drug infusion procedures.\n* Participation in infusion procedures eligible for observation according to the study protocol.\n\nExclusion Criteria:\n\n* Healthcare professionals not directly involved in antineoplastic drug administration.\n* Healthcare professionals working outside participating study sites.\n* Temporary staff not routinely involved in infusion activities during the observation period.\n* Refusal to participate in study activities where local regulations require participant notification.","ALL","18 Years",{"count":20,"type":21},40,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate infusion alarms, particularly air-in-line alarms, during antineoplastic drug infusion in oncology care settings.\n\nThe main questions it aims to answer are:\n\nHow frequently do infusion alarms occur, and what types of alarms are observed during antineoplastic drug infusion? How long does it take healthcare professionals to manage infusion alarms and restore infusion continuity? What strategies do healthcare professionals use to manage infusion alarms? How do healthcare professionals evaluate the user experience of different infusion technologies?\n\nParticipants will be healthcare professionals involved in antineoplastic drug infusion. They will not receive any experimental intervention. Researchers will observe routine infusion procedures and collect data on alarm events, alarm management, infusion technologies, and user experience.",[25,26,27,28],"Infusion Safety","Medication Safety","Antineoplastic Drug Administration","Air-in-Line Alarm",[30,31,32,33,34,35,36,37,38],"Antineoplastic agents","Infusion pumps","Air-in-line alarms","Oncology nursing","High-alert medications","User experience","Infusion safety","Alarm management","Entrustable Professional Activities","NOT_YET_RECRUITING","2026-07-16",{"date":42,"type":43},"2026-07-22","ACTUAL",{"date":45,"type":21},"2026-07-01",{"date":47,"type":21},"2028-06-01",{"name":49,"class":50},"Associazione Italiana Infermieri di Area Oncologica","OTHER",5]